TY - JOUR AU - Fernandez, J. AU - Acevedo, J. AU - Wiest, R. AU - Gustot, T. AU - Amoros, A. AU - Deulofeu, C. AU - Reverter, E. AU - Martinez, J. AU - Saliba, F. AU - Jalan, R. PY - 2018 DA - 2018// TI - Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis JO - Gut VL - 67 UR - https://doi.org/10.1136/gutjnl-2017-314240 DO - 10.1136/gutjnl-2017-314240 ID - Fernandez2018 ER - TY - JOUR AU - Hubener, P. AU - Braun, G. AU - Fuhrmann, V. PY - 2018 DA - 2018// TI - Acute-on-chronic liver failure: a diagnostic and therapeutic challenge for intensive care JO - Med Klin Intensivmed Notfmed VL - 113 UR - https://doi.org/10.1007/s00063-017-0263-3 DO - 10.1007/s00063-017-0263-3 ID - Hubener2018 ER - TY - JOUR AU - Moreau, R. AU - Jalan, R. AU - Gines, P. AU - Pavesi, M. AU - Angeli, P. AU - Cordoba, J. AU - Durand, F. AU - Gustot, T. AU - Saliba, F. AU - Domenicali, M. PY - 2013 DA - 2013// TI - Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis JO - Gastroenterology VL - 144 UR - https://doi.org/10.1053/j.gastro.2013.02.042 DO - 10.1053/j.gastro.2013.02.042 ID - Moreau2013 ER - TY - JOUR PY - 2018 DA - 2018// TI - EASL clinical practice guidelines for the management of patients with decompensated cirrhosis JO - J Hepatol VL - 69 UR - https://doi.org/10.1016/j.jhep.2018.03.024 DO - 10.1016/j.jhep.2018.03.024 ID - ref4 ER - TY - JOUR AU - Fuhrmann, V. AU - Whitehouse, T. AU - Wendon, J. PY - 2018 DA - 2018// TI - The ten tips to manage critically ill patients with acute-on-chronic liver failure JO - Intensive Care Med VL - 44 UR - https://doi.org/10.1007/s00134-018-5078-z DO - 10.1007/s00134-018-5078-z ID - Fuhrmann2018 ER - TY - JOUR AU - Jalan, R. AU - Fernandez, J. AU - Wiest, R. AU - Schnabl, B. AU - Moreau, R. AU - Angeli, P. AU - Stadlbauer, V. AU - Gustot, T. AU - Bernardi, M. AU - Canton, R. PY - 2014 DA - 2014// TI - Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013 JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2014.01.024 DO - 10.1016/j.jhep.2014.01.024 ID - Jalan2014 ER - TY - JOUR AU - Fernandez, J. AU - Prado, V. AU - Trebicka, J. AU - Amoros, A. AU - Gustot, T. AU - Wiest, R. AU - Deulofeu, C. AU - Garcia, E. AU - Acevedo, J. AU - Fuhrmann, V. PY - 2019 DA - 2019// TI - Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe JO - J Hepatol VL - 70 UR - https://doi.org/10.1016/j.jhep.2018.10.027 DO - 10.1016/j.jhep.2018.10.027 ID - Fernandez2019 ER - TY - JOUR AU - Rhodes, A. AU - Evans, L. E. AU - Alhazzani, W. AU - Levy, M. M. AU - Antonelli, M. AU - Ferrer, R. AU - Kumar, A. AU - Sevransky, J. E. AU - Sprung, C. L. AU - Nunnally, M. E. PY - 2017 DA - 2017// TI - Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 JO - Intensive Care Med VL - 43 UR - https://doi.org/10.1007/s00134-017-4683-6 DO - 10.1007/s00134-017-4683-6 ID - Rhodes2017 ER - TY - JOUR AU - Staufer, K. AU - Roedl, K. AU - Kivaranovic, D. AU - Drolz, A. AU - Horvatits, T. AU - Rasoul-Rockenschaub, S. AU - Zauner, C. AU - Trauner, M. AU - Fuhrmann, V. PY - 2017 DA - 2017// TI - Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications JO - Liver Int VL - 37 UR - https://doi.org/10.1111/liv.13389 DO - 10.1111/liv.13389 ID - Staufer2017 ER - TY - JOUR AU - Heintz, B. H. AU - Matzke, G. R. AU - Dager, W. E. PY - 2009 DA - 2009// TI - Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.5.562 DO - 10.1592/phco.29.5.562 ID - Heintz2009 ER - TY - JOUR AU - Thyrum, P. T. AU - Yeh, C. AU - Birmingham, B. AU - Lasseter, K. PY - 1997 DA - 1997// TI - Pharmacokinetics of meropenem in patients with liver disease JO - Clin Infect Dis VL - 24 UR - https://doi.org/10.1093/clinids/24.Supplement_2.S184 DO - 10.1093/clinids/24.Supplement_2.S184 ID - Thyrum1997 ER - TY - JOUR AU - Drolz, A. AU - Horvatits, T. AU - Rutter, K. AU - Landahl, F. AU - Roedl, K. AU - Meersseman, P. AU - Wilmer, A. AU - Kluwe, J. AU - Lohse, A. W. AU - Kluge, S. PY - 2019 DA - 2019// TI - Lactate improves prediction of short-term mortality in critically Ill patients with cirrhosis: a multinational study JO - Hepatology VL - 69 UR - https://doi.org/10.1002/hep.30151 DO - 10.1002/hep.30151 ID - Drolz2019 ER - TY - JOUR AU - Knaus, W. A. AU - Draper, E. A. AU - Wagner, D. P. AU - Zimmerman, J. E. PY - 1985 DA - 1985// TI - APACHE II: a severity of disease classification system JO - Crit Care Med VL - 13 UR - https://doi.org/10.1097/00003246-198510000-00009 DO - 10.1097/00003246-198510000-00009 ID - Knaus1985 ER - TY - JOUR AU - Vincent, J. L. AU - Moreno, R. AU - Takala, J. AU - Willatts, S. AU - Mendonca, A. AU - Bruining, H. AU - Reinhart, C. K. AU - Suter, P. M. AU - Thijs, L. G. PY - 1996 DA - 1996// TI - The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine JO - Intensive Care Med VL - 22 UR - https://doi.org/10.1007/BF01709751 DO - 10.1007/BF01709751 ID - Vincent1996 ER - TY - JOUR AU - Savic, R. M. AU - Karlsson, M. O. PY - 2009 DA - 2009// TI - Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions JO - AAPS J VL - 11 UR - https://doi.org/10.1208/s12248-009-9133-0 DO - 10.1208/s12248-009-9133-0 ID - Savic2009 ER - TY - STD TI - Holford N. The visual predictive check–superiority to standard diagnostic (Rorschach) plots. In: Populations approach group Europe conference abstract (PAGE 14) 2005. ID - ref16 ER - TY - JOUR AU - Ette, E. I. AU - Sun, H. AU - Ludden, T. M. PY - 1998 DA - 1998// TI - Balanced designs in longitudinal population pharmacokinetic studies JO - J Clin Pharmacol VL - 38 UR - https://doi.org/10.1002/j.1552-4604.1998.tb04446.x DO - 10.1002/j.1552-4604.1998.tb04446.x ID - Ette1998 ER - TY - STD TI - Ehmann L, Zoller M, Minichmayr I, Scharf C, Frey L, Vogeser M, Huisinga W, Zander J, Kloft C. Pharmacokinetics of meropenem in critically ill patients with varying renal function. In: Populations Approach Group Europe Conference Abstract (PAGE 25) 2016. ID - ref18 ER - TY - STD TI - Antimicrobial wild type distributions of microorganisms https://mic.eucast.org/Eucast2/. UR - https://mic.eucast.org/Eucast2/ ID - ref19 ER - TY - JOUR AU - Mouton, J. W. AU - Muller, A. E. AU - Canton, R. AU - Giske, C. G. AU - Kahlmeter, G. AU - Turnidge, J. PY - 2017 DA - 2017// TI - MIC-based dose adjustment: facts and fables JO - J Antimicrob Chemother VL - 73 UR - https://doi.org/10.1093/jac/dkx427 DO - 10.1093/jac/dkx427 ID - Mouton2017 ER - TY - JOUR AU - Braune, S. AU - Konig, C. AU - Roberts, J. A. AU - Nierhaus, A. AU - Steinmetz, O. AU - Baehr, M. AU - Kluge, S. AU - Langebrake, C. PY - 2018 DA - 2018// TI - Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study JO - Crit Care VL - 22 UR - https://doi.org/10.1186/s13054-018-1940-1 DO - 10.1186/s13054-018-1940-1 ID - Braune2018 ER - TY - JOUR AU - Christensson, B. A. AU - Nilsson-Ehle, I. AU - Hutchison, M. AU - Haworth, S. J. AU - Oqvist, B. AU - Norrby, S. R. PY - 1992 DA - 1992// TI - Pharmacokinetics of meropenem in subjects with various degrees of renal impairment JO - Antimicrob Agents Chemother VL - 36 UR - https://doi.org/10.1128/AAC.36.7.1532 DO - 10.1128/AAC.36.7.1532 ID - Christensson1992 ER - TY - JOUR AU - Thalhammer, F. AU - Horl, W. H. PY - 2000 DA - 2000// TI - Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy JO - Clin Pharmacokinet VL - 39 UR - https://doi.org/10.2165/00003088-200039040-00003 DO - 10.2165/00003088-200039040-00003 ID - Thalhammer2000 ER - TY - JOUR AU - Jamal, J. A. AU - Mat-Nor, M. B. AU - Mohamad-Nor, F. S. AU - Udy, A. A. AU - Wallis, S. C. AU - Lipman, J. AU - Roberts, J. A. PY - 2015 DA - 2015// TI - Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration JO - Int J Antimicrob Agents VL - 45 UR - https://doi.org/10.1016/j.ijantimicag.2014.09.009 DO - 10.1016/j.ijantimicag.2014.09.009 ID - Jamal2015 ER - TY - JOUR AU - Choudhury, A. AU - Kumar, M. AU - Sharma, B. C. AU - Maiwall, R. AU - Pamecha, V. AU - Moreau, R. AU - Chawla, Y. K. AU - Duseja, A. AU - Mahtab, M. AU - Rahman, S. PY - 2017 DA - 2017// TI - Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of ‘golden window’: a prospective study JO - J Gastroenterol Hepatol VL - 32 UR - https://doi.org/10.1111/jgh.13799 DO - 10.1111/jgh.13799 ID - Choudhury2017 ER - TY - JOUR AU - Roberts, J. A. AU - Paul, S. K. AU - Akova, M. AU - Bassetti, M. AU - Waele, J. J. AU - Dimopoulos, G. AU - Kaukonen, K. M. AU - Koulenti, D. AU - Martin, C. AU - Montravers, P. PY - 2014 DA - 2014// TI - DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? JO - Clin Infect Dis VL - 58 UR - https://doi.org/10.1093/cid/ciu027 DO - 10.1093/cid/ciu027 ID - Roberts2014 ER - TY - JOUR AU - Yu, Z. AU - Pang, X. AU - Wu, X. AU - Shan, C. AU - Jiang, S. PY - 2018 DA - 2018// TI - Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: a meta-analysis JO - PLoS ONE VL - 13 UR - https://doi.org/10.1371/journal.pone.0201667 DO - 10.1371/journal.pone.0201667 ID - Yu2018 ER - TY - JOUR AU - Guilhaumou, R. AU - Benaboud, S. AU - Bennis, Y. AU - Dahyot-Fizelier, C. AU - Dailly, E. AU - Gandia, P. AU - Goutelle, S. AU - Lefeuvre, S. AU - Mongardon, N. AU - Roger, C. PY - 2019 DA - 2019// TI - Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French society of pharmacology and therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and intensive care medicine (Societe Francaise d’Anesthesie et Reanimation-SFAR) JO - Crit Care VL - 23 UR - https://doi.org/10.1186/s13054-019-2378-9 DO - 10.1186/s13054-019-2378-9 ID - Guilhaumou2019 ER - TY - JOUR AU - Touny, M. AU - Guinaidy, M. AU - Abdel Barry, M. AU - Osman, L. AU - Sabbour, M. S. PY - 1992 DA - 1992// TI - Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites JO - J Antimicrob Chemother VL - 30 UR - https://doi.org/10.1093/jac/30.3.387 DO - 10.1093/jac/30.3.387 ID - Touny1992 ER - TY - JOUR AU - Touny, M. AU - Guinaidy, M. A. AU - Abd Barry, M. AU - Osman, L. AU - Sabbour, M. S. PY - 1991 DA - 1991// TI - Pharmacokinetics of ceftazidime in patients with liver cirrhosis and ascites JO - J Antimicrob Chemother VL - 28 UR - https://doi.org/10.1093/jac/28.1.95 DO - 10.1093/jac/28.1.95 ID - Touny1991 ER - TY - JOUR AU - Karjagin, J. AU - Lefeuvre, S. AU - Oselin, K. AU - Kipper, K. AU - Marchand, S. AU - Tikkerberi, A. AU - Starkopf, J. AU - Couet, W. AU - Sawchuk, R. J. PY - 2008 DA - 2008// TI - Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock JO - Clin Pharmacol Ther VL - 83 UR - https://doi.org/10.1038/sj.clpt.6100312 DO - 10.1038/sj.clpt.6100312 ID - Karjagin2008 ER - TY - JOUR AU - Ulldemolins, M. AU - Vaquer, S. AU - Llaurado-Serra, M. AU - Pontes, C. AU - Calvo, G. AU - Soy, D. AU - Martin-Loeches, I. PY - 2014 DA - 2014// TI - Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy JO - Crit Care VL - 18 UR - https://doi.org/10.1186/cc13938 DO - 10.1186/cc13938 ID - Ulldemolins2014 ER - TY - JOUR AU - Minichmayr, I. K. AU - Roberts, J. A. AU - Frey, O. R. AU - Roehr, A. C. AU - Kloft, C. AU - Brinkmann, A. PY - 2018 DA - 2018// TI - Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model JO - J Antimicrob Chemother VL - 73 UR - https://doi.org/10.1093/jac/dkx526 DO - 10.1093/jac/dkx526 ID - Minichmayr2018 ER - TY - JOUR AU - Pai, M. P. AU - Cojutti, P. AU - Pea, F. PY - 2015 DA - 2015// TI - Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections JO - Clin Pharmacokinet VL - 54 UR - https://doi.org/10.1007/s40262-015-0266-2 DO - 10.1007/s40262-015-0266-2 ID - Pai2015 ER - TY - STD TI - Ehmann L, Zoller M, Scharf C, Minichmayr IK, Vogeser M, Frey L, Zander J, Kloft C. Pharmacokinetic/pharmacodynamic analysis of meropenem in critically ill patients. In: ECCMID 2016. ID - ref35 ER - TY - JOUR AU - Ehmann, L. AU - Zoller, M. AU - Minichmayr, I. K. AU - Scharf, C. AU - Huisinga, W. AU - Zander, J. AU - Kloft, C. PY - 2019 DA - 2019// TI - Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis JO - Int J Antimicrob Agents. VL - 54 UR - https://doi.org/10.1016/j.ijantimicag.2019.06.016 DO - 10.1016/j.ijantimicag.2019.06.016 ID - Ehmann2019 ER - TY - JOUR AU - Burger, R. AU - Guidi, M. AU - Calpini, V. AU - Lamoth, F. AU - Decosterd, L. AU - Robatel, C. AU - Buclin, T. AU - Csajka, C. AU - Marchetti, O. PY - 2018 DA - 2018// TI - Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections JO - J Antimicrob Chemother VL - 73 UR - https://doi.org/10.1093/jac/dky370 DO - 10.1093/jac/dky370 ID - Burger2018 ER - TY - JOUR AU - Craig, W. A. PY - 1997 DA - 1997// TI - The pharmacology of meropenem, a new carbapenem antibiotic JO - Clin Infect Dis VL - 24 UR - https://doi.org/10.1093/clinids/24.Supplement_2.S266 DO - 10.1093/clinids/24.Supplement_2.S266 ID - Craig1997 ER - TY - JOUR AU - Ververs, T. F. AU - Dijk, A. AU - Vinks, S. A. AU - Blankestijn, P. J. AU - Savelkoul, J. F. AU - Meulenbelt, J. AU - Boereboom, F. T. PY - 2000 DA - 2000// TI - Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration JO - Crit Care Med VL - 28 UR - https://doi.org/10.1097/00003246-200010000-00006 DO - 10.1097/00003246-200010000-00006 ID - Ververs2000 ER - TY - JOUR AU - Kees, M. G. AU - Minichmayr, I. K. AU - Moritz, S. AU - Beck, S. AU - Wicha, S. G. AU - Kees, F. AU - Kloft, C. AU - Steinke, T. PY - 2016 DA - 2016// TI - Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients JO - J Clin Pharmacol VL - 56 UR - https://doi.org/10.1002/jcph.600 DO - 10.1002/jcph.600 ID - Kees2016 ER - TY - JOUR AU - Taccone, F. S. AU - Hites, M. AU - Beumier, M. AU - Scolletta, S. AU - Jacobs, F. PY - 2011 DA - 2011// TI - Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock JO - Curr Infect Dis Rep VL - 13 UR - https://doi.org/10.1007/s11908-011-0203-y DO - 10.1007/s11908-011-0203-y ID - Taccone2011 ER - TY - JOUR AU - Tam, V. H. AU - McKinnon, P. S. AU - Akins, R. L. AU - Rybak, M. J. AU - Drusano, G. L. PY - 2002 DA - 2002// TI - Pharmacodynamics of cefepime in patients with Gram-negative infections JO - J Antimicrob Chemother VL - 50 UR - https://doi.org/10.1093/jac/dkf130 DO - 10.1093/jac/dkf130 ID - Tam2002 ER - TY - JOUR AU - Manduru, M. AU - Mihm, L. B. AU - White, R. L. AU - Friedrich, L. V. AU - Flume, P. A. AU - Bosso, J. A. PY - 1997 DA - 1997// TI - In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients JO - Antimicrob Agents Chemother VL - 41 UR - https://doi.org/10.1128/AAC.41.9.2053 DO - 10.1128/AAC.41.9.2053 ID - Manduru1997 ER - TY - JOUR AU - Mouton, J. W. AU - Hollander, J. G. PY - 1994 DA - 1994// TI - Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model JO - Antimicrob Agents Chemother VL - 38 UR - https://doi.org/10.1128/AAC.38.5.931 DO - 10.1128/AAC.38.5.931 ID - Mouton1994 ER - TY - JOUR AU - Lodise, T. P. AU - Sorgel, F. AU - Melnick, D. AU - Mason, B. AU - Kinzig, M. AU - Drusano, G. L. PY - 2011 DA - 2011// TI - Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.01330-10 DO - 10.1128/AAC.01330-10 ID - Lodise2011 ER - TY - JOUR AU - Byl, B. AU - Jacobs, F. AU - Roucloux, I. AU - Franquen, P. AU - Cappello, M. AU - Thys, J. P. PY - 1999 DA - 1999// TI - Penetration of meropenem in lung, bronchial mucosa, and pleural tissues JO - Antimicrob Agents Chemother VL - 43 UR - https://doi.org/10.1128/AAC.43.3.681 DO - 10.1128/AAC.43.3.681 ID - Byl1999 ER - TY - JOUR AU - Mader, M. M. AU - Czorlich, P. AU - Konig, C. AU - Fuhrmann, V. AU - Kluge, S. AU - Westphal, M. AU - Grensemann, J. PY - 2018 DA - 2018// TI - Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis JO - Acta Neurochir VL - 160 UR - https://doi.org/10.1007/s00701-018-3680-z DO - 10.1007/s00701-018-3680-z ID - Mader2018 ER - TY - JOUR AU - Imani, S. AU - Buscher, H. AU - Marriott, D. AU - Gentili, S. AU - Sandaradura, I. PY - 2017 DA - 2017// TI - Too much of a good thing: a retrospective study of beta-lactam concentration-toxicity relationships JO - J Antimicrob Chemother VL - 72 UR - https://doi.org/10.1093/jac/dkx209 DO - 10.1093/jac/dkx209 ID - Imani2017 ER - TY - JOUR AU - Fantin, B. AU - Farinotti, R. AU - Thabaut, A. AU - Carbon, C. PY - 1994 DA - 1994// TI - Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa JO - J Antimicrob Chemother VL - 33 UR - https://doi.org/10.1093/jac/33.3.563 DO - 10.1093/jac/33.3.563 ID - Fantin1994 ER - TY - JOUR AU - Day, T. AU - Read, A. F. PY - 2016 DA - 2016// TI - Does high-dose antimicrobial chemotherapy prevent the evolution of resistance? JO - PLoS Comput Biol VL - 12 UR - https://doi.org/10.1371/journal.pcbi.1004689 DO - 10.1371/journal.pcbi.1004689 ID - Day2016 ER - TY - JOUR AU - Gugel, J. AU - Santos, P. e. r. e. i. r. a. A. AU - Pignatari, A. C. AU - Gales, A. C. PY - 2006 DA - 2006// TI - Beta-Lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa JO - Antimicrob Agents Chemother. VL - 50 UR - https://doi.org/10.1128/AAC.00144-06 DO - 10.1128/AAC.00144-06 ID - Gugel2006 ER - TY - JOUR AU - Rhodes, N. J. AU - Kuti, J. L. AU - Nicolau, D. P. AU - Wart, S. AU - Nicasio, A. M. AU - Liu, J. AU - Lee, B. J. AU - Neely, M. N. AU - Scheetz, M. H. PY - 2015 DA - 2015// TI - Defining clinical exposures of cefepime for gram-negative bloodstream infections that are associated with improved survival JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.01956-15 DO - 10.1128/AAC.01956-15 ID - Rhodes2015 ER - TY - JOUR AU - Ehmann, L. AU - Zoller, M. AU - Minichmayr, I. K. AU - Scharf, C. AU - Maier, B. AU - Schmitt, M. V. AU - Hartung, N. AU - Huisinga, W. AU - Vogeser, M. AU - Frey, L. PY - 2017 DA - 2017// TI - Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study JO - Crit Care VL - 21 UR - https://doi.org/10.1186/s13054-017-1829-4 DO - 10.1186/s13054-017-1829-4 ID - Ehmann2017 ER - TY - JOUR AU - Heil, E. L. AU - Nicolau, D. P. AU - Farkas, A. AU - Roberts, J. A. AU - Thom, K. A. PY - 2018 DA - 2018// TI - Pharmacodynamic target attainment for cefepime, meropenem, and piperacillin-tazobactam using a Pharmacokinetic/Pharmacodynamic-based dosing calculator in critically Ill patients JO - Antimicrob Agents Chemother VL - 62 UR - https://doi.org/10.1128/AAC.01008-18 DO - 10.1128/AAC.01008-18 ID - Heil2018 ER -